High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer

Renaud Sabatier (1) , Marc Lopez , Arnaud Guille (1) , Emilien Billon (1) , Nadine Carbuccia (1) , Séverine Garnier (1) , José Adelaide (1) , Jean-Marc Extra (2) , Maria-Antonietta Cappiello (3) , Emmanuelle Charafe-Jauffret (1) , Jihane Pakradouni (3) , Patrice Viens (1) , Anthony Gonçalves (1) , Max Chaffanet (1) , Daniel Birnbaum (1) , François Bertucci (1)

1 CRCM - Centre de Recherche en Cancérologie de Marseille
2 Service d'Oncologie Médicale
3 Institut Paoli-Calmettes

Domains: Life Sciences [q-bio]; Cancer

Renaud Sabatier, Marc Lopez, Arnaud Guille, Emilien Billon, Nadine Carbuccia, et al.. High Response to Cetuximab in a Patient With EGFR -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer. JCO precision oncology, 2019, 3, pp.1-8. ⟨10.1200/po.18.00310⟩. ⟨hal-03623686⟩